3D Models Are Reshaping Drug Development PrecliniX Is at the Forefront
A recent article in Drug Target Review highlights how 3D cell culture models are revolutionizing pre-clinical drug development by providing more accurate, human-relevant data earlier in the pipeline. These models better replicate human tissue complexity and immune interactions, offering a significant leap beyond traditional 2D cultures and animal models. At PrecliniX, we are advancing this […]
A New Era Begin FDA Plans to Phase Out Animal Testing Requirements
In a groundbreaking move, the FDA has announced plans to phase out animal testing requirements for monoclonal antibodies and other select drugs. This shift marks a historic step toward more humane, innovative, and human-relevant approaches in drug development. The updated strategy opens the door for modern testing platforms—like organ-on-a-chip systems, 3D tissue models, and advanced […]